Liquid Biopsy: Gritstone’s ctDNA Monitoring Assay Designed for Breadth and Depth Required for Tumor Fraction Monitoring ctDNA monitoring assay detects >80% (median) all targeted mutations and >90% of neoantigens identified based

EMERYVILLE, Calif., May 13, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today reported recent business highlights and financial results for the first quarter ended March 31, 2019.

Welcome and Overview of Gritstone’s Oncology Neoantigen Program Andrew Allen, MD, PhD, President and CEO, Gritstone bio, Inc Colorectal Cancer Therapy: Current Treatment Approaches -A Clear Need for

Gritstone bio, Inc. 5959 Horton Street, Suite 300 Emeryville, CA 94608 Re: Gritstone bio, Inc. Registration Statement on Form S-3 Filed December 22, 2023 File No. 333-276242 Dear Andrew Allen: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for

Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases. Gritstone develops its products by leveraging two key pillars—first, a proprietary artificial intelligence-based platform, Gritstone EDGE™, which is designed ...

2023年2月27日 · Gritstone is working to create the world’s most potent vaccines. We leverage our innovative vectors and payloads to train multiple arms of the immune system to attack critical disease targets and have programs in viral diseases and solid tumors.

2024年5月18日 · SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Section 16. Form 4 or Form 5 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934

Gritstone. About Us. Our Unique Story Leadership Board of Directors. Our Platforms. Proprietary Technologies Approach to Cancer Approach to ID Treatment Approach to ID Prevention Scientific Publications. Our Pipeline. Vaccine Pipeline GRANITE SLATE HIV Therapeutic CORAL. Career Opportunities ...

The Investor Relations website contains information about Gritstone bio's business for stockholders, potential investors, and financial analysts.

The Investor Relations website contains information about Gritstone bio's business for stockholders, potential investors, and financial analysts.